The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125658321 12565832 1 I 20151126 20160706 20160718 20160718 EXP IT-MINISAL02-366135 IT-TEVA-676060ACC TEVA 63.08 YR M Y 0.00000 20160718 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125658321 12565832 1 PS DICLOFENAC SODIUM. DICLOFENAC SODIUM 1 Oral 150 MILLIGRAM DAILY; Y 75219 150 MG
125658321 12565832 2 I ENAPREN - 5 MG COMPRESSE - MERCK SHARP AND DOHME LIMITED ENALAPRIL MALEATE 1 Oral 1 DOSAGE FORMS DAILY; Y 0 1 DF
125658321 12565832 3 I PRITOR - 40 MG COMPRESSE - BAYER PHARMA AG TELMISARTAN 1 Oral 1 DOSAGE FORMS DAILY; Y 0 1 DF
125658321 12565832 4 C ELIQUIS APIXABAN 1 Oral 5 MG U 0 5 MG
125658321 12565832 5 C LASIX FUROSEMIDE 1 Oral 4 DF U 0 4 DF
125658321 12565832 6 C LUVION - 100 MG CAPSULE RIGIDE 2 Oral 1 DF U 0 1 DF CAPSULE
125658321 12565832 7 C NOVORAPID - 100 U/ML SOLUZIONE INIETTABILE 2 Subcutaneous 34 IU U 0 34 IU
125658321 12565832 8 C LANTUS - 100 IU/ML SOLUZIONE INIETTABILE 2 Subcutaneous 10 IU U 0 10 IU
125658321 12565832 9 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MG U 0 300 MG
125658321 12565832 10 C AMIODARONE AMIODARONE 1 200 MG U 0 200 MG
125658321 12565832 11 C METOPROLOL. METOPROLOL 1 200 MG U 0 200 MG
125658321 12565832 12 C ETHYL ESTERS OF POLYUNSATURATED FATTY ACIDS 2 1 DF U 0 1 DF
125658321 12565832 13 C SIMVASTATIN. SIMVASTATIN 1 Oral 20 MG U 0 20 MG
125658321 12565832 14 C OMEPRAZOLE. OMEPRAZOLE 1 20 MG U 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125658321 12565832 1 Product used for unknown indication
125658321 12565832 2 Product used for unknown indication
125658321 12565832 3 Product used for unknown indication
125658321 12565832 4 Product used for unknown indication
125658321 12565832 5 Product used for unknown indication
125658321 12565832 6 Product used for unknown indication
125658321 12565832 7 Product used for unknown indication
125658321 12565832 8 Product used for unknown indication
125658321 12565832 9 Product used for unknown indication
125658321 12565832 10 Product used for unknown indication
125658321 12565832 11 Product used for unknown indication
125658321 12565832 12 Product used for unknown indication
125658321 12565832 13 Product used for unknown indication
125658321 12565832 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125658321 12565832 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125658321 12565832 Acute kidney injury
125658321 12565832 Drug interaction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125658321 12565832 2 20150227 20151126 0
125658321 12565832 3 20140407 20151126 0